1. Home
  2. RCKT vs CNMD Comparison

RCKT vs CNMD Comparison

Compare RCKT & CNMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RCKT
  • CNMD
  • Stock Information
  • Founded
  • RCKT 1999
  • CNMD 1970
  • Country
  • RCKT United States
  • CNMD United States
  • Employees
  • RCKT N/A
  • CNMD N/A
  • Industry
  • RCKT Biotechnology: Pharmaceutical Preparations
  • CNMD Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • RCKT Health Care
  • CNMD Health Care
  • Exchange
  • RCKT Nasdaq
  • CNMD Nasdaq
  • Market Cap
  • RCKT 1.9B
  • CNMD 2.2B
  • IPO Year
  • RCKT N/A
  • CNMD 1987
  • Fundamental
  • Price
  • RCKT $16.99
  • CNMD $74.32
  • Analyst Decision
  • RCKT Strong Buy
  • CNMD Buy
  • Analyst Count
  • RCKT 9
  • CNMD 6
  • Target Price
  • RCKT $53.22
  • CNMD $82.83
  • AVG Volume (30 Days)
  • RCKT 661.9K
  • CNMD 427.0K
  • Earning Date
  • RCKT 11-19-2024
  • CNMD 10-30-2024
  • Dividend Yield
  • RCKT N/A
  • CNMD 1.07%
  • EPS Growth
  • RCKT N/A
  • CNMD 127.53
  • EPS
  • RCKT N/A
  • CNMD 4.22
  • Revenue
  • RCKT N/A
  • CNMD $1,288,116,000.00
  • Revenue This Year
  • RCKT N/A
  • CNMD $7.17
  • Revenue Next Year
  • RCKT $382.35
  • CNMD $7.80
  • P/E Ratio
  • RCKT N/A
  • CNMD $17.67
  • Revenue Growth
  • RCKT N/A
  • CNMD 10.23
  • 52 Week Low
  • RCKT $15.98
  • CNMD $61.05
  • 52 Week High
  • RCKT $32.53
  • CNMD $117.27
  • Technical
  • Relative Strength Index (RSI)
  • RCKT 47.69
  • CNMD 68.42
  • Support Level
  • RCKT $16.12
  • CNMD $68.55
  • Resistance Level
  • RCKT $18.17
  • CNMD $77.99
  • Average True Range (ATR)
  • RCKT 0.75
  • CNMD 2.46
  • MACD
  • RCKT 0.06
  • CNMD 1.56
  • Stochastic Oscillator
  • RCKT 41.09
  • CNMD 79.56

About RCKT Rocket Pharmaceuticals Inc.

Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis.

About CNMD CONMED Corporation

Conmed Corp is a Utica, New York-based medical equipment company that focuses on sports medicine procedures and general surgeries. The firm currently reports through two reporting units, orthopedic surgery, and general surgery. From a geographic perspective, the firm is U.S.-centric, with maximum domestic sales accounting for revenue, EMEA accounting for second place, APAC at third, and the non-U.S. Americas region driving the remaining revenue.

Share on Social Networks: